Abcellera Long Term Debt To Capitalization from 2010 to 2024
ABCL Stock | USD 3.85 0.01 0.26% |
Long Term Debt To Capitalization | First Reported 2010-12-31 | Previous Quarter 0.05820978 | Current Value 0.0938 | Quarterly Volatility 0.05937601 |
Check Abcellera BiologicsInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abcellera main balance sheet or income statement drivers, such as Net Interest Income of 44.4 M, Interest Income of 44.4 M or Depreciation And Amortization of 20.4 M, as well as many exotic indicators such as Price To Sales Ratio of 41.25, Dividend Yield of 0.0 or PTB Ratio of 1.36. Abcellera financial statements analysis is a perfect complement when working with Abcellera BiologicsInc Valuation or Volatility modules.
Abcellera | Long Term Debt To Capitalization |
Latest Abcellera BiologicsInc's Long Term Debt To Capitalization Growth Pattern
Below is the plot of the Long Term Debt To Capitalization of Abcellera BiologicsInc over the last few years. It is Abcellera BiologicsInc's Long Term Debt To Capitalization historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Abcellera BiologicsInc's overall financial position and show how it may be relating to other accounts over time.
Long Term Debt To Capitalization | 10 Years Trend |
|
Long Term Debt To Capitalization |
Timeline |
Abcellera Long Term Debt To Capitalization Regression Statistics
Arithmetic Mean | 0.08 | |
Geometric Mean | 0.06 | |
Coefficient Of Variation | 74.98 | |
Mean Deviation | 0.03 | |
Median | 0.07 | |
Standard Deviation | 0.06 | |
Sample Variance | 0 | |
Range | 0.2738 | |
R-Value | 0.01 | |
Mean Square Error | 0 | |
R-Squared | 0.0002 | |
Significance | 0.96 | |
Slope | 0.0002 | |
Total Sum of Squares | 0.05 |
Abcellera Long Term Debt To Capitalization History
About Abcellera BiologicsInc Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Abcellera BiologicsInc income statement, its balance sheet, and the statement of cash flows. Abcellera BiologicsInc investors use historical funamental indicators, such as Abcellera BiologicsInc's Long Term Debt To Capitalization, to determine how well the company is positioned to perform in the future. Although Abcellera BiologicsInc investors may use each financial statement separately, they are all related. The changes in Abcellera BiologicsInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Abcellera BiologicsInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Abcellera BiologicsInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Abcellera BiologicsInc. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Long Term Debt To Capitalization | 0.06 | 0.09 |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Abcellera BiologicsInc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out the analysis of Abcellera BiologicsInc Correlation against competitors. For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.Note that the Abcellera BiologicsInc information on this page should be used as a complementary analysis to other Abcellera BiologicsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for Abcellera Stock analysis
When running Abcellera BiologicsInc's price analysis, check to measure Abcellera BiologicsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abcellera BiologicsInc is operating at the current time. Most of Abcellera BiologicsInc's value examination focuses on studying past and present price action to predict the probability of Abcellera BiologicsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abcellera BiologicsInc's price. Additionally, you may evaluate how the addition of Abcellera BiologicsInc to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Fundamental Analysis View fundamental data based on most recent published financial statements |
Is Abcellera BiologicsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abcellera BiologicsInc. If investors know Abcellera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abcellera BiologicsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.459 | Earnings Share (0.51) | Revenue Per Share 0.123 | Quarterly Revenue Growth (0.18) | Return On Assets (0.1) |
The market value of Abcellera BiologicsInc is measured differently than its book value, which is the value of Abcellera that is recorded on the company's balance sheet. Investors also form their own opinion of Abcellera BiologicsInc's value that differs from its market value or its book value, called intrinsic value, which is Abcellera BiologicsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abcellera BiologicsInc's market value can be influenced by many factors that don't directly affect Abcellera BiologicsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abcellera BiologicsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Abcellera BiologicsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abcellera BiologicsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.